HWM
IMUX icon

HB Wealth Management’s Immunic IMUX Stock Holding History

HB Wealth Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,145
Closed -$102K – 1762
2026
Q1 		$102K Hold
9,145
– – ﹤0.01% 1500
2025
Q4 		$48.8K Hold
9,145
– – ﹤0.01% 1382
2025
Q3 		$80.6K Buy
+9,145
New +$80.7K ﹤0.01% 1311
2025
Q2 		– Sell
-5,240
Closed -$57.1K – 1229
2025
Q1 		$57.1K Sell
5,240
-2,600
-33% -$28.1K ﹤0.01% 1191
2024
Q4 		$80.5K Buy
+7,840
New +$98.8K ﹤0.01% 1037

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

HB Wealth Management's IMUX Position: Q2 2026 in Review

HB Wealth Management sold out of Immunic (IMUX) in Q2 2026, closing a stake of 9,145 shares — an estimated $102K sold.

HB Wealth Management first reported a position in IMUX in Q4 2024 and held it in 5 quarters. The position peaked at $102K in Q1 2026. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • HB Wealth Management reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • HB Wealth Management sold 9,145 Immunic shares in Q2 2026, an estimated $102K.
  • HB Wealth Management first reported a position in Immunic in Q4 2024 and held it in 5 quarters.
  • HB Wealth Management's Immunic position peaked at $102K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.